The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.
- Investigator
- Hans K Ghayee
- Ages
- 18 Years - 74 Years
- Sexes
- All
Clinical trials
-
A Study to Evaluate Atumelnant in Adults with Congenital Adrenal Hyperplasia